Approach to a 40-Year-Old Male with Loss of Libido and Decreased Sexual Stamina
Begin by measuring morning total testosterone levels on two separate occasions, along with LH, FSH, and prolactin to determine if androgen deficiency is driving his symptoms—if testosterone is below 300 ng/dL with symptoms, offer testosterone therapy to improve libido. 1
Initial Diagnostic Workup
Hormonal Assessment
- Obtain morning total testosterone levels on at least two separate occasions (testosterone levels fluctuate and single measurements are unreliable)
- Measure free testosterone if total testosterone is borderline (250-350 ng/dL)
- Check LH and FSH to distinguish primary testicular failure from secondary hypogonadism
- Measure prolactin to rule out hyperprolactinemia (a treatable cause of low libido) 2
- Consider IGF-1 levels, as recent evidence suggests correlation with libido 3
Critical Medical History Elements
- Medication review: Antihypertensives, antidepressants, antipsychotics, and decongestants commonly cause sexual dysfunction 2
- Chronic diseases: Diabetes, hypertension, hyperlipidemia, and cardiovascular disease are major risk factors 2
- Substance use: Quantify alcohol intake, tobacco use, and illicit drug use—all directly impair sexual function 2
- Psychiatric symptoms: Screen for depression (PHQ-9) and anxiety (GAD-7), as both strongly correlate with reduced libido 4, 3
- Relationship factors: Assess domestic and dyadic relationship quality, as relationship disturbances are the most common cause of decreased libido 5, 4
Physical Examination Priorities
- Digital rectal examination and baseline PSA if age ≥40 years (required before testosterone therapy) 1
- Testicular examination for size, consistency, and masses
- Secondary sexual characteristics to assess for hypogonadism
- Cardiovascular assessment: ED is a sentinel marker for cardiovascular disease—this is a pivotal opportunity to assess cardiovascular risk 6, 7
Treatment Algorithm Based on Testosterone Levels
If Total Testosterone <300 ng/dL on Two Occasions
Offer testosterone therapy after explicit discussion of risks, benefits, and uncertain long-term safety 1. The Endocrine Society guidelines specifically recommend testosterone for men with low testosterone and low libido (Grade 2 recommendation).
Before initiating testosterone:
- Ensure PSA <4 ng/mL and normal digital rectal examination
- Obtain baseline hematocrit
- Rule out prostate cancer, breast cancer, sleep apnea, and polycythemia (hematocrit >52%) 2
- Screen for benign prostatic hyperplasia symptoms
Testosterone formulation selection:
- Intramuscular testosterone enanthate or cypionate is preferred as first-line due to significantly lower cost with similar efficacy and safety compared to transdermal formulations 8
- Dosing: 50-150 mg IM every 7-14 days (smaller, more frequent doses maintain stable levels better than 200-300 mg every 2-3 weeks) 2
- Alternative: 100 mg on days 1,11, and 21 of each month 2
Monitoring on testosterone therapy:
- Reassess symptoms at 12 months—discontinue if no improvement in sexual function 8
- Check hematocrit at 3-6 months (stop if >54%, evaluate for hypoxia/sleep apnea) 1
- Monitor PSA at 3-6 months, then per age-appropriate screening guidelines 1
- Obtain urology consultation if PSA increases >1.4 ng/mL in any 12-month period or PSA velocity >0.4 ng/mL/year 1
If Testosterone is Normal or Borderline
Do not initiate testosterone therapy—focus on other etiologies 1, 8. The evidence for testosterone in eugonadal men is insufficient and potentially harmful.
Address modifiable risk factors:
- Optimize glycemic control if diabetic
- Adjust or discontinue offending medications (work with prescribing physician)
- Aggressively treat hyperlipidemia and hypertension
- Mandate smoking cessation and alcohol reduction 2
Consider PDE5 inhibitor trial (sildenafil, tadalafil, vardenafil, or avanafil) if erectile dysfunction is present, as decreased stamina may reflect erectile difficulty 6. Provide proper dosing instructions and titrate to optimal efficacy.
Refer to mental health specialist if depression, anxiety, or relationship conflict is identified—psychotherapy and psychosexual counseling are effective as monotherapy or adjunct to medical treatment 6, 2
Common Pitfalls to Avoid
Do not treat based on a single testosterone measurement—levels fluctuate significantly and require confirmation 1
Do not assume all sexual dysfunction in middle-aged men is testosterone deficiency—erectile dysfunction and androgen deficiency are independently distributed disorders that may coexist but have distinct pathophysiology 1
Do not overlook cardiovascular risk assessment—ED is as strong a predictor of cardiac events as smoking or family history of MI. Communicate this risk to the patient and primary care provider 6
Do not continue testosterone indefinitely without reassessment—if no improvement in sexual function by 12 months, discontinue therapy 8
Do not ignore relationship factors—dissatisfaction with the relationship is the most common factor in depressed desire and requires couples counseling, not just medical intervention 5, 4
Special Considerations for This 40-Year-Old Patient
At age 40, this patient is younger than typical age-related hypogonadism populations. The 4-year duration suggests a chronic process rather than acute illness. Primary reduced libido (without hypogonadism, hyperprolactinemia, or psychopathology) is characterized by relationship disturbances and overall metabolic health 4. If testosterone is normal, focus heavily on psychosocial factors, relationship quality, and medication effects rather than pursuing hormonal treatment.
The distinction between primary versus secondary reduced libido fundamentally changes management—secondary causes (hypogonadism, hyperprolactinemia, depression, medications) have specific treatments, while primary reduced libido requires relationship counseling and lifestyle modification 4.